Cargando…

Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study

OBJECTIVE: People with diabetes show great variability in weight gain and duration of obesity at the time of diagnosis. BMI trajectories and other cardiometabolic risk factors prior to type 2 diabetes were investigated. METHODS: A total of 6,223 participants from the Rotterdam Study cohort were incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Nano, Jana, Dhana, Klodian, Asllanaj, Eralda, Sijbrands, Eric, Ikram, M. Arfan, Dehghan, Abbas, Muka, Taulant, Franco, Oscar H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317538/
https://www.ncbi.nlm.nih.gov/pubmed/32379398
http://dx.doi.org/10.1002/oby.22802
_version_ 1783550651788165120
author Nano, Jana
Dhana, Klodian
Asllanaj, Eralda
Sijbrands, Eric
Ikram, M. Arfan
Dehghan, Abbas
Muka, Taulant
Franco, Oscar H.
author_facet Nano, Jana
Dhana, Klodian
Asllanaj, Eralda
Sijbrands, Eric
Ikram, M. Arfan
Dehghan, Abbas
Muka, Taulant
Franco, Oscar H.
author_sort Nano, Jana
collection PubMed
description OBJECTIVE: People with diabetes show great variability in weight gain and duration of obesity at the time of diagnosis. BMI trajectories and other cardiometabolic risk factors prior to type 2 diabetes were investigated. METHODS: A total of 6,223 participants from the Rotterdam Study cohort were included. BMI patterns before diagnosis of diabetes were identified through latent class trajectories. RESULTS: During a mean follow‐up of 13.7 years, 565 participants developed type 2 diabetes. Three distinct trajectories of BMI were identified, including the “progressive overweight” group (n = 481, 85.1%), “progressive weight loss” group (n = 59, 10.4%), and “persistently high BMI” group (n = 25, 4.4%). The majority, the progressive overweight group, was characterized by a steady increase of BMI in the overweight range 10 years before diabetes diagnosis. The progressive weight loss group had fluctuations of glucose and marked beta cell function loss. The persistently high BMI group was characterized by a slight increase in insulin levels and sharp increase of insulin resistance accompanied by a rapid decrease of beta cell function. CONCLUSIONS: Heterogeneity of BMI changes prior to type 2 diabetes was found in a middle‐aged and elderly white population. Prevention strategies should be tailored rather than focusing only on high‐risk individuals.
format Online
Article
Text
id pubmed-7317538
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73175382020-06-29 Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study Nano, Jana Dhana, Klodian Asllanaj, Eralda Sijbrands, Eric Ikram, M. Arfan Dehghan, Abbas Muka, Taulant Franco, Oscar H. Obesity (Silver Spring) Original Articles OBJECTIVE: People with diabetes show great variability in weight gain and duration of obesity at the time of diagnosis. BMI trajectories and other cardiometabolic risk factors prior to type 2 diabetes were investigated. METHODS: A total of 6,223 participants from the Rotterdam Study cohort were included. BMI patterns before diagnosis of diabetes were identified through latent class trajectories. RESULTS: During a mean follow‐up of 13.7 years, 565 participants developed type 2 diabetes. Three distinct trajectories of BMI were identified, including the “progressive overweight” group (n = 481, 85.1%), “progressive weight loss” group (n = 59, 10.4%), and “persistently high BMI” group (n = 25, 4.4%). The majority, the progressive overweight group, was characterized by a steady increase of BMI in the overweight range 10 years before diabetes diagnosis. The progressive weight loss group had fluctuations of glucose and marked beta cell function loss. The persistently high BMI group was characterized by a slight increase in insulin levels and sharp increase of insulin resistance accompanied by a rapid decrease of beta cell function. CONCLUSIONS: Heterogeneity of BMI changes prior to type 2 diabetes was found in a middle‐aged and elderly white population. Prevention strategies should be tailored rather than focusing only on high‐risk individuals. John Wiley and Sons Inc. 2020-05-07 2020-06 /pmc/articles/PMC7317538/ /pubmed/32379398 http://dx.doi.org/10.1002/oby.22802 Text en © 2020 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society (TOS). This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Nano, Jana
Dhana, Klodian
Asllanaj, Eralda
Sijbrands, Eric
Ikram, M. Arfan
Dehghan, Abbas
Muka, Taulant
Franco, Oscar H.
Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study
title Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study
title_full Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study
title_fullStr Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study
title_full_unstemmed Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study
title_short Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study
title_sort trajectories of bmi before diagnosis of type 2 diabetes: the rotterdam study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317538/
https://www.ncbi.nlm.nih.gov/pubmed/32379398
http://dx.doi.org/10.1002/oby.22802
work_keys_str_mv AT nanojana trajectoriesofbmibeforediagnosisoftype2diabetestherotterdamstudy
AT dhanaklodian trajectoriesofbmibeforediagnosisoftype2diabetestherotterdamstudy
AT asllanajeralda trajectoriesofbmibeforediagnosisoftype2diabetestherotterdamstudy
AT sijbrandseric trajectoriesofbmibeforediagnosisoftype2diabetestherotterdamstudy
AT ikrammarfan trajectoriesofbmibeforediagnosisoftype2diabetestherotterdamstudy
AT dehghanabbas trajectoriesofbmibeforediagnosisoftype2diabetestherotterdamstudy
AT mukataulant trajectoriesofbmibeforediagnosisoftype2diabetestherotterdamstudy
AT francooscarh trajectoriesofbmibeforediagnosisoftype2diabetestherotterdamstudy